Voxel Based Morphometry In Patients With Psychotic Versus Non Psychotic Depression
1 other identifier
observational
66
0 countries
N/A
Brief Summary
- 1.To examine structural brain changes in patients with depression measured using voxel based morphometry(VBM) in comparison with healthy subjects.
- 2.Relation between grey mater volume (GMV) and other structural changes, and the severity of clinical symptoms.
- 3.To study if there is structural brain difference between psychotic and non-psychotic depression
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2021
CompletedStudy Start
First participant enrolled
September 1, 2021
CompletedFirst Posted
Study publicly available on registry
September 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2022
CompletedSeptember 5, 2021
August 1, 2021
1 year
August 24, 2021
August 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Study the structural brain changes in different areas in patients with psychotic depression and non-psychotic depression.
Investigators will use MRI the voxel based morphometry to measure the volume of different areas in grey and white matter in depressed patients and compare them to structure of brain in healthy group.
one year
Examine different variables related to major depressive disorder and their specific relation to structural changes in different areas in brain
Investigators will measure the changes occur in volume of different areas in brain with different types of depression. Investigators will measure the changes in volume of different areas in brain which occur by the effect of psychotic features. Investigators will measure the effect of suicide on changes of volume of different areas of brain.
one year
Interventions
Voxel based morphometry through analysis of 3D T1 weighted sequence to assess total intracranial volume. All participants were scanned on the 1.5Tesla MR scanner (Achieva, Philips Medical Systems, Best, NL) with a 16-channel head coil at the diagnostic radiology department.
Eligibility Criteria
The study included two groups: Group (A): patients' group diagnosed with major depressive disorder (MDD) which include (44) patients aged 18-60 years' old who attended psychiatric outpatient's clinic and who is admitted in psychiatric unit of Assiut university hospitals. This group is further subdivided according to DSM 5 Criteria into 2 subgroups: Major depression with psychotic disorder and Major depression without psychotic disorder. Group (B): control group which consists of (22) healthy cross matching individuals.
You may qualify if:
- Age 18-60 years old.
- Based on DSM5 Criteria: MDD with or without psychotic features.
You may not qualify if:
- Patients under 18 years old or above 60
- Pregnant or lactating women.
- Other current or past major psychiatric disorders
- History or concurrent neurological disease(seizures) or prior head trauma with evidence of consequent cognitive impairment.
- First degree family history of schizophrenia if the participant is less than 33 years old (mean age of onset of schizophrenia plus two standard deviations) to exclude possible prodromal phase of schizophrenia.
- Unstable medical condition (i.e., any active illness that may affect the brain as blood dyscrasis, lymphomas, endocrinopathies, renal failure, chronic obstructive lung disease, systemic autoimmune disorders or Malignancy).
- Patients being treated with steroids or hormonal therapy .
- Current substances or alcohol use disorders (past diagnosis allowed if in remission for more than 6 months
- Contraindications for MRI as:
- Metal implants or paramagnetic objects contained within the body (including heart pacemaker or surgical prosthesis)
- Claustrophobia significant enough to interfere with MRI
- Refusal of informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (8)
Sacher J, Neumann J, Funfstuck T, Soliman A, Villringer A, Schroeter ML. Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorder. J Affect Disord. 2012 Oct;140(2):142-8. doi: 10.1016/j.jad.2011.08.001. Epub 2011 Sep 3.
PMID: 21890211BACKGROUNDJaaskelainen E, Juola T, Korpela H, Lehtiniemi H, Nietola M, Korkeila J, Miettunen J. Epidemiology of psychotic depression - systematic review and meta-analysis. Psychol Med. 2018 Apr;48(6):905-918. doi: 10.1017/S0033291717002501. Epub 2017 Sep 12.
PMID: 28893329BACKGROUNDLui S, Zhou XJ, Sweeney JA, Gong Q. Psychoradiology: The Frontier of Neuroimaging in Psychiatry. Radiology. 2016 Nov;281(2):357-372. doi: 10.1148/radiol.2016152149.
PMID: 27755933BACKGROUNDO'Connor S, Agius M. A systematic review of structural and functional MRI differences between psychotic and nonpsychotic depression. Psychiatr Danub. 2015 Sep;27 Suppl 1:S235-9.
PMID: 26417770BACKGROUNDSchmaal L, Veltman DJ, van Erp TG, Samann PG, Frodl T, Jahanshad N, Loehrer E, Tiemeier H, Hofman A, Niessen WJ, Vernooij MW, Ikram MA, Wittfeld K, Grabe HJ, Block A, Hegenscheid K, Volzke H, Hoehn D, Czisch M, Lagopoulos J, Hatton SN, Hickie IB, Goya-Maldonado R, Kramer B, Gruber O, Couvy-Duchesne B, Renteria ME, Strike LT, Mills NT, de Zubicaray GI, McMahon KL, Medland SE, Martin NG, Gillespie NA, Wright MJ, Hall GB, MacQueen GM, Frey EM, Carballedo A, van Velzen LS, van Tol MJ, van der Wee NJ, Veer IM, Walter H, Schnell K, Schramm E, Normann C, Schoepf D, Konrad C, Zurowski B, Nickson T, McIntosh AM, Papmeyer M, Whalley HC, Sussmann JE, Godlewska BR, Cowen PJ, Fischer FH, Rose M, Penninx BW, Thompson PM, Hibar DP. Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Mol Psychiatry. 2016 Jun;21(6):806-12. doi: 10.1038/mp.2015.69. Epub 2015 Jun 30.
PMID: 26122586BACKGROUNDYuan Y, Zhang Z, Bai F, Yu H, You J, Shi Y, Qian Y, Liu W, Jiang T. Larger regional white matter volume is associated with executive function deficit in remitted geriatric depression: an optimized voxel-based morphometry study. J Affect Disord. 2009 May;115(1-2):225-9. doi: 10.1016/j.jad.2008.09.018. Epub 2008 Oct 21.
PMID: 18945494BACKGROUNDLai CH. Gray matter volume in major depressive disorder: a meta-analysis of voxel-based morphometry studies. Psychiatry Res. 2013 Jan 30;211(1):37-46. doi: 10.1016/j.pscychresns.2012.06.006. Epub 2012 Nov 10.
PMID: 23146253BACKGROUNDArnone D, Job D, Selvaraj S, Abe O, Amico F, Cheng Y, Colloby SJ, O'Brien JT, Frodl T, Gotlib IH, Ham BJ, Kim MJ, Koolschijn PC, Perico CA, Salvadore G, Thomas AJ, Van Tol MJ, van der Wee NJ, Veltman DJ, Wagner G, McIntosh AM. Computational meta-analysis of statistical parametric maps in major depression. Hum Brain Mapp. 2016 Apr;37(4):1393-404. doi: 10.1002/hbm.23108. Epub 2016 Feb 8.
PMID: 26854015BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Yasser Elserogy, MD
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecturer
Study Record Dates
First Submitted
August 24, 2021
First Posted
September 5, 2021
Study Start
September 1, 2021
Primary Completion
September 1, 2022
Study Completion
November 1, 2022
Last Updated
September 5, 2021
Record last verified: 2021-08